Kirkland & Ellis advised General Catalyst Group Management, LLC (“General Catalyst”), a leading venture capital firm, on the closing of its second heath assurance focused fund (“Health Assurance Fund II”), which raised $670 million.  Health Assurance Fund II will enable General Catalyst to continue to invest in innovative companies that are accelerating consumer-centric and data-driven healthcare solutions designed to help people stay well, while bending the cost curve. The Kirkland team was led by investment funds partners Matthew Smith, Jonathan Lipnick and Matthew Block, with involvement from investment funds partner Daniel Lavon-Krein, investment funds regulatory solutions partner Alpa Patel, tax partner Lee Morlock, investment funds associates Charles Chen, Ben Turin, Daniel Sylvia and Thomas Kelley, investment funds regulatory solutions associate Chris Pristouris, and tax associate Steven Cantor.